Cargando…
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to significant morbidity or mortality. Indeed, NF1...
Autores principales: | Bergqvist, Christina, Servy, Amandine, Valeyrie-Allanore, Laurence, Ferkal, Salah, Combemale, Patrick, Wolkenstein, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998847/ https://www.ncbi.nlm.nih.gov/pubmed/32014052 http://dx.doi.org/10.1186/s13023-020-1310-3 |
Ejemplares similares
-
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
por: Groh, Matthieu, et al.
Publicado: (2023) -
Neurofibromatosis I and multiple sclerosis
por: Bergqvist, Christina, et al.
Publicado: (2020) -
Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)
por: Ingen-Housz-Oro, Saskia, et al.
Publicado: (2018) -
French recommendations for the management of systemic sclerosis
por: Hachulla, Eric, et al.
Publicado: (2021) -
Lymphoproliferative malignancies in patients with neurofibromatosis 1
por: Bergqvist, Christina, et al.
Publicado: (2021)